Previous reports have shown that ECT2 has Rho GTPase activity, which may promote the occurrence and progression of squamous cell carcinoma by mediating the overexpression of Rho A (Mendez and Ramirez, 2013; Chen et al., 2015; Sun et al., 2020). Here, ECT2 is linked to squamous cell carcinoma.